Radiopharmaceutical therapy uses radioactive tracers to target and destroy cancer cells, reducing common side effects experienced while undergoing other cancer treatments, according to an Oct. 15 news release from Fox Chase.
The society’s Comprehensive Radiopharmaceutical Therapy Center of Excellence designation signifies a center is an “in-depth, prestigious and well-equipped” facility for radiopharmaceutical therapy, the release said. The center must adhere to specific guidelines to maintain its designation.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
